Related Experiment Video
Updated: Jun 13, 2026
Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
Published on: November 4, 2010
Developing therapeutics for the treatment of pediatric asthma
1Novartis Pharma AG, Pharmaceutical Development Unit Inhalation, PO Box 4002, Basel, Switzerland. fadi.eskandar@novartis.com
Insights
Effective pediatric asthma treatments are lacking due to poor adherence and inefficient inhaler use in children. New, child-friendly inhaler systems are needed to improve asthma control and quality of life for kids.
Area of Science:
- Pediatric Pulmonology
- Respiratory Medicine
- Drug Delivery Systems
Background:
- Despite advances in inhaled corticosteroids, pediatric asthma control remains suboptimal.
- Poor adherence and inefficient inhaler technique in children contribute to inadequate asthma management.
- Current inhalers are often adult-designed with minor modifications, failing to meet pediatric needs.
Purpose of the Study:
- To highlight the unmet needs in pediatric asthma treatment.
- To identify key factors contributing to poor asthma control in children.
- To advocate for the development of specialized pediatric inhaler devices.
Main Methods:
- Review of current challenges in pediatric asthma management.
- Analysis of factors affecting treatment efficacy in young patients.
- Examination of regulatory mandates for pediatric drug development.
Main Results:
- Poor compliance and adherence significantly impair treatment effectiveness.
- Pediatric patients struggle with adult-designed inhalers, leading to inefficient drug delivery.
- A lack of child-specific inhaler devices persists despite regulatory incentives.
Conclusions:
- Development of patient-centric medication and delivery systems is crucial for pediatric asthma.
- Innovations in inhaler design tailored for children are essential for improving outcomes.
- Addressing inhaler usability is key to enhancing asthma control in pediatric populations.
Abstract:
The main goals for developing effective treatments for pediatric asthma are to improve the quality of life of children with asthma by reducing symptoms and the frequency of exacerbations, to allow undisturbed sleep and performance of daily activities, and to ensure a more healthy adult future. Despite advances in modern medical care and the introduction of effective therapies, such as inhaled corticosteroids, poor asthma control exists in clinical practice. This lack of control can be attributed to two primary factors: (i) poor compliance and adherence to treatment; and (ii) poor efficiency of inhalation drug delivery, resulting from the inability of young children to correctly use inhalers that were designed for adults. Both the FDA and EMEA have mandated pediatric testing regulations for drugs indicated for pediatric use and established incentives for the development of such agents; however, there are no inhalers on the market that have been specifically designed to meet the unique needs of children because most inhalers were developed for adults and then used for the treatment of children following minor modifications. Significant effort needs to be invested in the area of pediatric asthma to increase the availability of high-quality, patient-centric medication and delivery systems.
More Related Videos
07:28Dry Powder and Nebulized Aerosol Inhalation of Pharmaceuticals Delivered to Mice Using a Nose-only Exposure System
Published on: April 6, 2017
05:45A Refined Aerosol-Based Intratracheal Bleomycin Delivery Method for Reproducible and Minimally Invasive Mouse Models of Pulmonary Fibrosis
Published on: January 16, 2026
Related Concept Videos
01:30Asthma-IV: Diagnostic and Management
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
01:20Asthma: Pathogenesis and Management
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
01:17Drugs Used in Lower Respiratory Disorders: Overview
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
01:19Antiasthma Drugs: Leukotriene Modifiers
Leukotriene modifiers work through two distinct mechanisms:
01:30Asthma-IV: Nursing Management
First, in...